<DOC>
	<DOCNO>NCT00987116</DOCNO>
	<brief_summary>Pathology - Generalized myasthenia gravis ( MG ) cause muscle weakness significant impact daily life activity also , respiratory bulbar muscle involve , life-threatening . Rationale - Additionally thymectomy , indication still debate absence thymoma , long-term treatment generalize myasthenia gravis include usually prednisone azathioprine . However , use scheme prescribe taper corticosteroid MG result important cumulative dose prednisone . Indeed , twelve month , 50 percent patient still daily treat least 18 mg prednisone proportion patient remission longer take prednisone low ( Palace NEWSOM Davis , Neurology 1998 ) . Prolonged corticosteroid therapy accompany various major side effect , hypertension , osteoporosis , weight gain , glaucoma . Therefore , taper , eventually discontinue , prednisone earlier relevant therapeutic goal . For reason , investigator compare standard one , strategy consist rapid decrease corticosteroid . Objective - To assess whether , patient generalize MG require long-term treatment corticosteroid azathioprine , strategy rapid tapering allow discontinue rapidly prednisone equivalent efficacy classical strategy .</brief_summary>
	<brief_title>Study Comparing Two Tapering Strategies Prednisone Myasthenia Gravis</brief_title>
	<detailed_description>Rapid strategy consist decrease prednisone dose monthly consultation patient fulfil criterion improvement minimal manifestation state , order discontinue twelve month . The start dose 0.75 mg/kg/day . Classical strategy consist decrease prednisone dose monthly consultation patient fulfil criterion minimal manifestation state , order discontinue twelve month . The start dose 1.5 mg/kg/2days . Duration follow-up 15 month . In arm , Myasthenia Muscular Score ( MMS ) , activity Daily Living Scale ( ADLS ) , MGFA Clinical Classification MGFA Post-Intervention Status well prednisone azathioprine side effect monthly assess senior neurologist blind treatment group . A second physician , aware patient 's therapeutic group , prescribe prednisone dose taper month , accord MGFA Post-Intervention Status . In case worsening , prednisone dose increase . In case exacerbation , patient hospitalise eventually IvIg infusion plasma exchange . In case severe side effect , prednisone reduce irrespectively MGFA Post-Intervention Status . In case side effect , azathioprine replace mycophenolate mofetil .</detailed_description>
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Myasthenia Gravis</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<criteria>Written consent patient , inform Generalized MG grade III , IV V Classification MGFA Followup 15 month possible accepted patient Age &lt; 18 &gt; 80 year Pregnancy Myasthenia grade I II MGFA Patients already treat prednisone azathioprine Contraindication prednisone azathioprine Other associate disease require treatment prednisone azathioprine Weight &gt; 100kg Invasive thymoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Myasthenia gravis</keyword>
	<keyword>Steroids side effect</keyword>
	<keyword>Comparison strategy taper steroid</keyword>
	<keyword>Generalized MG correspond grade III , IV V MGFA</keyword>
</DOC>